{
    "Disability (follow up: 2 years; assessed with: HAQ)": {
      "No of studies": ["1"],
      "Study design": "randomised trials",
      "Risk of bias": "not serious",
      "Inconsistency": "not serious",
      "Indirectness": "not serious",
      "Imprecision": ["very serious", "a"],
      "Other considerations": "none",
      "No of patients": {
        "csDMARDs + long-term low-dose GCs": ["77","b"],
        "csDMARDs monotherapy": ["74","c"]
      },
      "Effect": {
        "Relative (95% CI)": "-",
        "Absolute (95% CI)": "MD 0.22 higher (0.02 lower to 0.46 higher)"
      },
      "Certainty": "LOW",
      "Importance": "IMPORTANT"
    }
  }
  